Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare adenocarcinoma of the major and minor salivary glands, originating from basaloid, myoepithelial and ductal cells. While morphologically resembling basal cell carcinomas, it is a distinct entity. The tumor is not encapsulated, may invade locally, and less frequently may metastasize. It usually occurs in older patients.
Biomarker and diagnostic research for salivary gland basal cell adenocarcinoma has been reported in the published literature.
No clinical trials have been registered for salivary gland basal cell adenocarcinoma.
19 publications have been identified in PubMed for salivary gland basal cell adenocarcinoma. Research spans Case Report / Case Series (47%), Review / Meta-Analysis (21%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 47% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:54 AM UTC
Research summaries
4 |
21% |
Testing and diagnosis research | 3 | 16% |
Laboratory research | 2 | 11% |
Clinical study results | 1 | 5% |
Kissinger CR (2026). [PMID: 41593408](https://pubmed.ncbi.nlm.nih.gov/41593408/). *Journal of cancer research and clinical oncology*. [Case Report / Case Series]
Yang W (2026). [PMID: 41576835](https://pubmed.ncbi.nlm.nih.gov/41576835/). *Annals of diagnostic pathology*. [Case Report / Case Series]
Chiari F (2026). [PMID: 42165879](https://pubmed.ncbi.nlm.nih.gov/42165879/). *Eur Arch Otorhinolaryngol*. [Review / Meta-Analysis]
Lin H (2025). [PMID: 38044562](https://pubmed.ncbi.nlm.nih.gov/38044562/). *Ear, nose, & throat journal*. [Basic Science / Preclinical]
Yagi H (2025). [PMID: 40360858](https://pubmed.ncbi.nlm.nih.gov/40360858/). *Virchows Archiv : an international journal of pathology*. [Review / Meta-Analysis]
Walker M (2025). [PMID: 40108726](https://pubmed.ncbi.nlm.nih.gov/40108726/). *Journal of medical case reports*. [Diagnostic / Biomarker]
Wong K (2025). [PMID: 40389436](https://pubmed.ncbi.nlm.nih.gov/40389436/). *Nature communications*. [Clinical Trial Publication]
Amminou L (2025). [PMID: 41141120](https://pubmed.ncbi.nlm.nih.gov/41141120/). *Cureus*. [Case Report / Case Series]
Mijares KE (2025). [PMID: 41264039](https://pubmed.ncbi.nlm.nih.gov/41264039/). *Head and neck pathology*. [Diagnostic / Biomarker]
Geetha SD (2025). [PMID: 39644132](https://pubmed.ncbi.nlm.nih.gov/39644132/). *Diagnostic cytopathology*. [Diagnostic / Biomarker]
AI-curated news mentioning salivary gland basal cell adenocarcinoma
Updated May 21, 2026
A systematic review and pooled analysis of basal cell adenocarcinoma of the parotid gland reveals key prognostic factors and survival outcomes. This research provides valuable insights for clinicians managing this rare cancer type.